Join Foley & Lardner LLP, CollectiveMinds, and HSBC Innovation Banking in Silicon Valley for Capital Connect, an insightful afternoon exploring the dynamic landscape of the biopharma industry.
This year’s event features a panel of leading experts discussing investment trends beyond mega-deals, including financing prospects for non-mega deals, strategies for rising above the noise, and the challenges and opportunities for both biopharma CEOs and investors. The discussion will also cover the pre-seed and seed market, offering valuable perspectives and networking opportunities to help you navigate this rapidly evolving sector and understand what’s happening beyond the headline-grabbing mega-deals.
Speakers:
Tara Kochis, Collective Minds (Moderator)
Jonathan Norris, HSBC Innovation Banking (Panelist)
Antoinette Konski, Foley & Lardner (Panelist)
Nick O’Keefe, Foley & Lardner (Panelist)
Shahram Seyedin-Noor, Civilization Ventures (Panelist)
Nicole Paulk, Siren Biotechnology (Panelist)
Paul Stone, 5AM Ventures (Panelist)
Agenda:
3:30 – 4:00 p.m. Check In
4:00 – 4:05 p.m. Brief Welcome
4:05 – 4:25 p.m. State of the Industry – Jonathan Norris, HSBC
4:25 – 5:25 p.m. Panel Discussion
5:25 – 5:40 p.m. Brief Wrap up
5:40 – 7:00 p.m. Networking Reception
